[More care for a limited budget; a case for a better use of the efficiency criteria].
A systematic consideration of the cost-effectiveness in decisions concerning the financing and implementation of healthcare technologies would contribute to the efficiency of the Dutch healthcare system. This consideration applies to the initial decision to finance a project, the periodic testing of this on the basis of practice data and the policy to promote a cost-effective approach in daily practice (via practice guidelines). Bearing in mind that the government has decided to allocate few additional resources to healthcare, it should undertake measures to ensure the systematic use of such information in these steps. The National Institute for Clinical Excellence (NICE) in the United Kingdom can serve as an example, where broadly supported guidelines are drawn up with systematic attention for the cost-effectiveness and the implications for healthcare. Within this context the question arises as to whether a Dutch variant of NICE is needed.
Rutten
F F H
FF
Erasmus Medisch Centrum, Instituut Beleid en Management Gezondheidszorg, Postbus 1738, 3000 DR Rotterdam. f.rutten@bmg.eur.nl
Brouwer
W B F
WB
D020811:Biomedical Technology; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017408:Guidelines as Topic; D017048:Health Care Costs; D006801:Humans; D009313:National Health Programs / Q000191:economics* / Q000458:organization & administration; D009426:Netherlands; D013673:Technology Assessment, Biomedical / Q000191:economics*